Loading...
| A03171 | Pages: NA | Dec 2021 | 15654 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Consumer Healthcare Market
Request Now !Consumer healthcare deals with products in wellness, oral health, nutrition, and skin health. Consumer healthcare products mainly constitute over-the-counter (OTC) drugs that include medicines, which are sold directly to a consumer without a prescription from a healthcare professional.
The major factors that contribute to the growth of the consumer healthcare market include high demand for self-medication, growing healthcare costs, increasing geriatric population who are more prone to contracting diseases, deterioration in mental health, and shift from medication prescription to OTC products. Moreover, the approval of wellness & preventive medicine and a rise in disposable income further boosts the market growth. However, stringent governmental regulations and the presence of counterfeit pharmaceuticals restrain the market. On the contrary, development & accelerated use of online sources, along with the increasing demand for branded products, private labels, and OTC generics will further provide numerous opportunities in the near future.
The global consumer healthcare market is segmented on the basis of products, distribution network, and region. Based on product, it is bifurcated into OTC pharmaceuticals and dietary supplements. On the basis of distribution network, the market is categorized into departmental stores, independent retailers, pharmacies or drugstores, specialist retailers, and supermarkets or hypermarkets. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Johnson & Johnson, Sanofi, Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Amway, and BASF SE.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIE SUMMARY
2.1. CXO PERSPECTIE
CHAPTER 3 MARKET OERIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top inestment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Driers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 CONSUMER HEALTHCARE MARKET, BY PRODUCT
4.1. OERIEW
4.1.1. Market size and forecast
4.2. OTC PHARMACEUTICALS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. DIETARY SUPPLEMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION NETWORK
5.1. OERIEW
5.1.1. Market size and forecast
5.2. DEPARTMENTAL STORES
5.2.1. Market size and forecast
5.3. INDEPENDENT RETAILERS
5.3.1. Market size and forecast
5.4. PHARMACIES OR DRUGSTORES
5.4.1. Market size and forecast
5.5. SPECIALIST RETAILERS
5.5.1. Market size and forecast
5.6. SUPERMARKETS OR HYPERMARKETS
5.6.1. Market size and forecast
CHAPTER 6 CONSUMER HEALTHCARE MARKET, BY REGION
6.1. OERIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America consumer healthcare market by product
6.2.5. North America consumer healthcare market by distribution network
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe consumer healthcare market by product
6.3.5. Europe consumer healthcare market by distribution network
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific consumer healthcare market by product
6.4.5. Asia-Pacific consumer healthcare market by distribution network
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA consumer healthcare market by product
6.5.5. LAMEA consumer healthcare market by distribution network
CHAPTER 7 COMPANY PROFILES
7.1. JOHNSON & JOHNSON
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moes and deelopments
7.2. SANOFI
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moes and deelopments
7.3. PFIZER INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moes and deelopments
7.4. ABBOTT LABORATORIES
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moes and deelopments
7.5. GLAXOSMITHKLINE PLC
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moes and deelopments
7.6. BOEHRINGER INGELHEIM GMBH
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moes and deelopments
7.7. TEA PHARMACEUTICAL INDUSTRIES LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moes and deelopments
7.8. BAYER AG
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moes and deelopments
7.9. AMWAY
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moes and deelopments
7.10. BASF SE
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moes and deelopments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
